Show simple item record

dc.contributor.authorvan der Graaf, WTAen_US
dc.date.accessioned2017-04-21T16:54:24Z
dc.date.issued2016-07en_US
dc.identifier.citationLancet (London, England), 2016, 388 (10043), pp. 442 - 444en_US
dc.identifier.issn0140-6736en_US
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/617
dc.identifier.eissn1474-547Xen_US
dc.identifier.doi10.1016/s0140-6736(16)30788-7en_US
dc.formatPrint-Electronicen_US
dc.format.extent442 - 444en_US
dc.languageengen_US
dc.language.isoengen_US
dc.rights.urihttp://www.rioxx.net/licenses/all-rights-reserveden_US
dc.subjectHumansen_US
dc.subjectSarcomaen_US
dc.subjectSoft Tissue Neoplasmsen_US
dc.titleOlaratumab in soft-tissue sarcomas.en_US
dc.typeJournal Article
rioxxterms.versionofrecord10.1016/s0140-6736(16)30788-7en_US
rioxxterms.licenseref.startdate2016-07en_US
rioxxterms.typeJournal Article/Reviewen_US
dc.relation.isPartOfLancet (London, England)en_US
pubs.issue10043en_US
pubs.notesNot knownen_US
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Clinical Studies/Clinical and Translational Sarcoma
pubs.publication-statusPublisheden_US
pubs.volume388en_US
pubs.embargo.termsNot knownen_US
icr.researchteamClinical and Translational Sarcomaen_US
dc.contributor.icrauthorvan der Graaf, Wilhelminaen_US


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record